Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
Breaking down HIV exclusions in cancer clinical trials

As an eligibility barrier cracks, a lung cancer patient gets a new lease on life.

Published
10 June 2019
From
Fred Hutchinson Cancer Research Center
Checkpoint Immunotherapy Is Safe and Effective for HIV-Positive People With Cancer

Keytruda and Imfinzi were well tolerated and responses were similar to those seen in HIV-negative people.

Published
07 June 2019
From
Poz
Advanced Stage at Cancer Diagnosis, Higher Mortality in US Patients With HIV

Cancer patients with HIV in the U.S. are more likely to be diagnosed at advanced disease stages and experience higher cancer-related mortality than cancer patients without HIV, researchers say.

Published
21 May 2019
From
Reuters
FDA's Breakthrough Designation Granted for Kaposi Sarcoma Therapy

Celgene’s pomalidomide (Pomalyst) has been granted Breakthrough Therapy designation by the FDA for the treatment of patients with previously-treated HIV-positive Kaposi sarcoma (KS) and patients with HIV-negative KS, according to a press release.

Published
15 May 2019
From
Pharmacy Times
Should Gay Men Be Getting Anal Pap Smears?

It’s time to talk about Pap smears, guys. More specifically, if you’re a man who has sex with other men, or MSM, you should consider talking to your medical provider about getting an anal Pap smear.

Published
13 May 2019
From
Slate
Recent Immunosuppression, Persistently High HIV Load Predict Lymphoma Risk

Recent immunosuppression, which causes a drop in CD4 T-cell levels, and prolonged exposure to high HIV viral load are two independent predictors of non-Hodgkin’s lymphoma among people living with HIV, a recent study shows.

Published
08 May 2019
From
Lymphoma News Today
Only six percent of people at highest risk for HIV are vaccinated against HPV, survey suggests

Just six percent of people at the highest risk for HIV infection are vaccinated against HPV, a new study suggests - putting them in greater danger of contracting either disease and of developing cancer.

Published
03 April 2019
From
Daily Mail
HIV status does not preclude receipt of curative cervical cancer therapy in Botswana

Women in Botswana with well-managed HIV had the same access to curative chemoradiotherapy for cervical cancer as women without HIV, according to results of an observational study published Cancer.

Published
27 February 2019
From
Healio
Using anti-cancer immunotherapy to fight HIV

Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have shown that immunotherapy treatments against cancer could reduce the amount of virus that persists in people on triple therapy. In a study published in the journal Nature Communications, they show, in the cells of people living with HIV, how these therapies reveal the virus - until now hidden in the hollows of infected cells - to the immune system.

Published
20 February 2019
From
Eurekalert Medicine & Health
A Cure for HPV? Not So Fast…

Can photodynamic therapy eliminate the virus than causes cervical, anal and oral cancer?

Published
11 February 2019
From
Poz
← First12345...27Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.